Medical oncologists' attitudes and practice in cancer pain management: a national survey.
J. Clin. Oncol., Dec;29(36):4769-75 (2011)
Treatment of cancer pain.
Lancet., Jun;377(9784):2236-47 (2011)
Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity.
J Pain., Apr;13(4):379-89 (2012)
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
J Pain., May;13(5):438-49 (2012)
Epidemiology of pain among outpatients in methadone maintenance treatment programs.
Drug Alcohol Depend., Aug (2012)
Recent advances in the treatment of cancer pain.
Clin Adv Hematol Oncol., Apr;8(4):272-4 (2010)
Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey.
South. Med. J., Aug;103(8):738-47 (2010)
A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain.
Pain., Dec;151(3):617-24 (2010)
Palliative medicine: from paradigm to best practice.
J Palliat Med., Oct;11(8):1092-3 (2008)
Opioids and the treatment of chronic pain: controversies, current status, and future directions.
Exp Clin Psychopharmacol., Oct;16(5):405-16 (2008)
L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.
J Pain Symptom Manage., Apr;37(4):622-31 (2009)
Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program.
Pain Med., Oct;9(7):911-7 (2008)
MMTP patients with chronic pain switching to pain management clinics. A problem or an acceptable practice?
Pain Med., Apr;9(3):359-64 (2008)
Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
J Pain Symptom Manage., May;35(5):458-68 (2008)
Measurement of QTc in patients receiving chronic methadone therapy.
J Pain Symptom Manage., Apr;29(4):385-91 (2005)
Access to care for chronic pain: racial and ethnic differences.
J Pain., May;6(5):301-14 (2005)
Improving end-of-life care: development and pilot-test of a clinical pathway.
J Pain Symptom Manage., Jun;29(6):529-43 (2005)
Cancer pain management.
Clin Adv Hematol Oncol., Jan;3(1):30-2 (2005)
Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain.
J Pain., Aug;7(8):583-91 (2006)
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
Clin J Pain., 22(9):805-11 (2006)
Opioid use and survival at the end of life: a survey of a hospice population.
J Pain Symptom Manage., Dec;32(6):532-40 (2006)
Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study.
J Pain Symptom Manage., Dec;32(6):551-9 (2006)
U.S. board-certified pain physician practices: uniformity and census data of their locations.
J Pain., Mar;8(3):244-50 (2007)
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
Clin J Pain., May;23(4):287-99 (2007)
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
Clin Ther., Sep;29(9):2022-30 (2007)
Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects.
J Pain., Aug;5(6):317-28 (2004)
Appropriate use of opioids for persistent non-cancer pain.
Lancet., 364(9436):739-40 (2004)
Adjuvant analgesics in cancer pain management.
Oncologist., 9(5):571-91 (2004)
Development of a brief assessment scale for caregivers of the medically ill.
J Pain Symptom Manage., Mar;29(3):245-54 (2005)
Opioid rotation in the management of refractory cancer pain.
J. Clin. Oncol., May;21(9 Suppl):87s-91s (2003)
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.
JAMA., May;289(18):2370-8 (2003)
Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
Support Care Cancer., Apr;12(4):268-73 (2004)
Management of fatigue in the cancer patient.
Oncology (Williston Park, N.Y.)., Mar;16(3):373-8, 381; discussion 381-2, 385-6, 388-9 (2002)
Is optimal pain relief at the end of life real relief?
Pain Med., Sep;3(3):289-91 (2002)
Ethical challenges in the care of patients with serious illness.
Pain Med., Jun;2(2):121-30 (2001)
Opioid rotation in the management of refractory cancer pain.
J. Clin. Oncol., Jan;20(1):348-52 (2002)
Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
J Pain Symptom Manage., Apr;23(4):292-300 (2002)
Advances in cancer pain management.
Hematol. Oncol. Clin. North Am., Jun;16(3):527-41 (2002)
Management of cancer pain.
Lancet., May;353(9165):1695-700 (1999)
Current pharmacotherapy of chronic pain.
J Pain Symptom Manage., Jan;19(1 Suppl):S16-20 (2000)
Treatment of temporal variations in chronic cancer pain.
Semin. Oncol., Oct;24(5 Suppl 16):S16-7-12 (1997)
Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction.
J Pain Symptom Manage., Sep;14(3 Suppl):S27-35 (1997)
The physical examination in cancer pain assessment.
Semin Oncol Nurs., Feb;13(1):25-9 (1997)
Implementing national standards for cancer pain management: program model and evaluation.
J Pain Symptom Manage., Dec;12(6):334-47; discussion 331-3 (1996)
Pain management: pharmacological approaches.
Cancer Treat. Res., 100:1-29 (1999)
Opioid rotation: the science and the limitations of the equianalgesic dose table.
J Pain Symptom Manage., Sep;38(3):426-39 (2009)
Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse.
Clin J Pain., Feb;22(2):173-81 (2006)
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
Curr Med Res Opin., Jan;23(1):223-33 (2007)
Pharmacologic management of neuropathic pain: evidence-based recommendations.
Pain., Dec;132(3):237-51 (2007)
Pain management and chemical dependency. Evolving perspectives.
JAMA., Aug;278(7):592-3 (1997)